Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase

Experimental and Clinical Endocrinology and Diabetes

Volumn 105, Issue 6, 1997, Pages 327-330

  Inukai, T ^a   Fujiwara, Y ^a   Tayama, K ^a   Aso, Y ^a   Ogino, K ^a   Takemura, Y ^a  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti GAD antibodies; C peptide; HbA(1c); IDDM; NIDDM

Indexed keywords

C PEPTIDE; ENZYME ANTIBODY; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A1C; PANCREAS ISLET CELL ANTIBODY;

ADULT; ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0030730022     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211773     Document Type: Article

References (25)

1. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark A: Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 298: 167-169, 1982
2. Baekkeskov S, Aanstroot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, Camilli PD: Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156, 1990
3. Bu DF, Erlander MG, Hitz BC, Tillakaratne NJK, Kaufman DL, Wagner-Mcpherson CB, Evans GA, Tobin AJ: Two human glutamate decarboxylase, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA, 89: 2115-2119, 1992
4. Christie MR, Brown TJ, Cassidy D: Binding of antibodies in sera from Type 1 (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissue. Evidence for antigenic and non-antigenic forms of the enzyme. Diabetologia 35: 380-384, 1992
5. DeAizpurua HJ, Harrison LC, Cram DS: An ELISA for antibodies to recombinant glutamic acid decarboxylase in IDDM. Diabetes 41: 1182-1187, 1992
6. Feldt-Rasmussen B, Dinesen B, Decker M: Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45: 539-544, 1985
7. Genovese S, Bonifacio E, McNally JM, Dean BM, Wegner R, Bosi E, Gale EAM, Bottazzo GF: Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35: 385-388, 1992
8. Hagopian WA, Karlsen AE, Gottsater A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyrberg T, Lernmark A: Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 91: 368-374, 1993
9. Karlsen AE, Hagopian WA, Grubin CE, Dube S, Disteche CM, Adler DA, Barmeier H, Mathewes S, Grant FJ, Foster D, Lernmark A: Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci USA 88: 8337-8341, 1991
10. Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GSP, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69-72, 1993
11. Kawasaki E, Moriuchi R, Watamnabe M, Saitoh K, Brunicardi FC, Watt PC, Yamaguchi T, Mullen Y, Akazawa S, Miyamto T, Nagataki S: Cloning and expression of large isoform of glutamic acid decarboxylase from human pancreotitic islet: Biochem Biophys Research Communi. 192, 1353-1359, 1993
12. Kawasaki E, Takino H, Yano M, Uotani S, Matsumoto K, Takao Y, Yamaguchi Y, Akazawa S, Nagataki S: Autoantibodies to giutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 43: 80-86, 1994
13. Kobayashi T, Itoh T, Kosaka K, Sato K, Tsuji K: Time course of islet cell antibodies and β-cell function in non-insulin-dependent stage of Type I diabetes. Diabetes 36: 510-517, 1987
14. Kobayashi T, Takemoto K, Nakanishi K, Kato N, Okubo M, Kajio H, Sugimoto T, Murase T, Kosaka K: Immunogenic and clinical characterization of slowly progressive IDDM. Diabetes Care 16: 780-788, 1993
15. Kobayashi T, Nakanishi K, Murase T, Kosaka K: Small does of subcutaneous insulin as a strategy for preventing slowly progressive β-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 45: 622-626, 1996
16. Myers MA, Rabin DU and Rowley MJ: Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes 44: 1290-1295, 1995
17. Roll U and Ziegler AG: Combined antibody screening for improved prediction of IDDD-Modern strategies. Exp Clin Endocrinol Diabetes 105: 1-14, 1997
18. Rossini A, Greiner D, Friedman H: Immunopathogenesis of diabetes mellitus. Diabetes Rev 1: 43-75, 1993
19. Rowley MJ, Mackay IR, Chen Q-Y, Knowles WJ, Zimmet PZ: Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 41: 548-551, 1992
20. Schmidli RS, Colman PG, Bonifacio E: Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies: Diabetes 44: 636-640, 1995
21. Service FJ, Rizza RA, Zimmerman BR, Dyck PJ, O'Brien PC, Melton III LJ: The classification of diabetes by clinical and C-peptide criteria. Diabetes Care 20: 198-201, 1997
22. Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, Camilli PD, Vicari AM: Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med: 318, 1012-1020, 1988
23. Thivolet CH, Tappaz M, Durand A, Petersen J, Steffanutti A, Chatelain P, Vialetters B, Scherbaum W, Orgiazzi J: Glutamic acid decarboxylase (GAD) autoantibodies are additional predicitve markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals. Diabetologia 35: 570-576, 1992
24. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42: 359-362, 1993
25. Tuomilehto J, Zimmet P, Mackay IR, Koskela P, Vidgren G, Toivanen L, Tuomilehto-Wolf E, Kohtamaki K, Stengard J, Rowley MJ: Antobodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343: 1383-1385, 1994